A novel lncRNA FPASL regulates fibroblast proliferation via the PI3K/AKT and MAPK signaling pathways in hypertrophic scar
Open Access
- 1 September 2022
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 55 (2) , 274-284
Abstract
Hypertrophic scar (HS) is a problem for numerous patients eagering to solve, especially after burns, and characterized by increased fibroblasts proliferation and collagen deposition. Increasing evidence demonstrate that lncRNAs contribute to development and progression of various diseases. However, the function of lncRNAs in hypertrophic scar formation remains poorly characterized. In this study, a novel fibroblast proliferation-associated lncRNA, named lncRNA FPASL (MSTRG.389905.1), which mainly localized in cytoplasm, is found downregulated in HS as detected by lncRNA microarray and qRT-PCR. Further studies characterize full-length FPASL and confirm that its no protein-coding potential. FPASL knockdown in fibroblasts triggers fibroblasts proliferation, whereas overexpressing FPASL directly attenuates proliferation of fibroblasts. Furthermore, target genes of the differentially expressed lncRNAs in HS and the matched adjacent normal tissues (NS) are enriched in fibroblasts proliferation signaling pathways in HS as determined by GO annotation and KEGG enrichment analysis, including the PI3K/AKT and MAPK signaling pathways. We demonstrate that knockdown of FPASL activates the PI3K/AKT and MAPK signaling pathways and specific inhibitors of PI3K/AKT and MAPK signaling pathways intervention can reverse the promotion of LNA-FPASL on fibroblasts proliferation. These findings contribute to a better understanding of hypertrophic scar in relation to lncRNAs and may act as a novel potential therapeutic target for hypertrophic scar.Keywords
This publication has 32 references indexed in Scilit:
- The Role of non-coding RNAs in colorectal cancer, with a focus on its autophagyPharmacology & Therapeutics, 2021
- Transdermal delivery of Chinese herbal medicine extract using dissolvable microneedles for hypertrophic scar treatmentActa Pharmaceutica Sinica B, 2021
- LNCcation: lncRNA localization and functionJournal of Cell Biology, 2021
- HOXA5 counteracts the function of pathological scar-derived fibroblasts by partially activating p53 signalingCell Death & Disease, 2021
- Secondary data mining of GEO database for long non-coding RNA and Competing endogenous RNA network in keloid-prone individualsAging, 2020
- LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathwayCell Death & Differentiation, 2020
- LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axesMolecular Cancer, 2020
- Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and ScarringInternational Journal of Molecular Sciences, 2020
- Overexpression of LncRNA AC067945.2 Down-Regulates Collagen Expression in Skin Fibroblasts and Possibly Correlates with the VEGF and Wnt Signalling PathwaysCellular Physiology and Biochemistry, 2018
- Inhibition of FKBP10 Attenuates Hypertrophic Scarring through Suppressing Fibroblast Activity and Extracellular Matrix DepositionJournal of Investigative Dermatology, 2017